NCT01395017

Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer

Nowotwór
rak trzustki
Faza badania
II
Sponsor badania
Otsuka
Termin
-
Linki
www.clinicaltrials.gov
Dane kontaktowe
Lublin; Olsztyn